Biogen Asks For Yet More Patience As Leqembi Sales Begin Slow Ascent

Skyclarys From Reata A More Immediate Revenue Source

 
• By Mandy Jackson
  
Climb to success - Man working hard and climbing to reach the top of hill
Leqembi and other new products will be slow to add revenue growth • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip